Quality Growth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Quality Growth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$4.3M	Sell	32,908 -500	-1%	-$62.2K	4.83%	6
2015 Q4	$4.7M	Buy	+33,408	New	+$4.63M	5.19%	5
2015 Q2	$5.77M	Sell	32,770 -1,631	-5%	-$293K	5.95%	5
2015 Q1	$5.94M	Buy	34,401 +4,257	+14%	+$731K	4.83%	5
2014 Q4	$4.93M	Sell	30,144 -7,080	-19%	-$1.18M	3.9%	6
2014 Q3	$5.98M	Sell	37,224 -276	-0.7%	-$42.4K	4.84%	5
2014 Q2	$5.47M	Hold	37,500	–	–	4.13%	6
2014 Q1	$4.75M	Hold	37,500	–	–	3.88%	6
2013 Q4	$4.75M	Buy	+37,500	New	+$3.88M	4.05%	5

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Quality Growth Management's JAZZ Position: Q1 2016 in Review

Quality Growth Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 1.5% in Q1 2016, selling an estimated $62.2K and leaving 32,908 shares worth $4.3M. The position accounts for 4.83% of the portfolio, ranked #6.

Quality Growth Management first reported a position in JAZZ in Q4 2013 and has held it in 9 quarters since. The position peaked at $5.98M in Q3 2014. 339 funds tracked by Wall St. Rank hold JAZZ as of Q1 2016.

Quality Growth Management held 32,908 shares of Jazz Pharmaceuticals worth $4.3M as of Q1 2016.
Quality Growth Management sold 500 Jazz Pharmaceuticals shares in Q1 2016, an estimated $62.2K.
Jazz Pharmaceuticals made up 4.83% of Quality Growth Management's portfolio in Q1 2016, its #6 holding.
Quality Growth Management first reported a position in Jazz Pharmaceuticals in Q4 2013 and has held it in 9 quarters since.
Quality Growth Management's Jazz Pharmaceuticals position peaked at $5.98M in Q3 2014.
339 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2016.

Based on Quality Growth Management's 13F filing for Q1 2016, filed 15 Apr 2016.